Archimedes’ Individualized Guidelines and Outcomes (IndiGO) Platform Deployed in Colorado Beacon Consortium

– Patient Engagement Key in Western Colorado Medical Practices –

SAN FRANCISCO--(BUSINESS WIRE)--Archimedes Inc., a healthcare modeling company, today announced that it has entered into an agreement with the Colorado Beacon Consortium (CBC) for the use of the Company’s Individualized Guidelines and Outcomes (IndiGO) platform, a physician and patient decision support tool. Initially, IndiGO will be used as part of a one-year program throughout the CBC’s medical practices to assist in the care of up to 100,000 patients.

“Increasing physician and patient collaboration is essential and the IndiGO platform serves an important role in a patient’s care plan decision-making process. By involving patients in discussions about their care, they develop a sense of ownership and involvement, thereby improving likelihood of adherence and positive outcomes.”

“Results generated by IndiGO can be used to inform physicians and patients of an individual’s risk of adverse events and benefits of treatment options during clinical visits to increase patient engagement,” said Peter Alperin, M.D., Archimedes’ vice president of medicine. “Increasing physician and patient collaboration is essential and the IndiGO platform serves an important role in a patient’s care plan decision-making process. By involving patients in discussions about their care, they develop a sense of ownership and involvement, thereby improving likelihood of adherence and positive outcomes.”

Health guidelines for care are crucially important aides for health care professionals in today’s medical practices. For nearly 30 years, physicians have used population-based guidelines that typically focus on one risk factor or condition and use finite parameters, such as the defined normal range for blood glucose levels and blood pressure, to determine whether or not a patient should receive treatment. These guidelines also help assess a patient’s risk for developing diabetes and having a heart attack or stroke. Because population-based guidelines use finite parameters, there are limitations when it comes to the continuous and changing nature associated with these risk factors. Individualized guidelines, which can be created via Archimedes’ IndiGO platform, can address these limitations by taking into account up to 30 different person-specific risk factors, making it possible to both increase quality and reduce costs.

“Physician leaders and primary care teams in our community believe that patient-centricity is critical in the deployment of advanced technology,” said Patrick Gordon, director at Colorado Beacon Consortium. “Powerful analytics are of little use unless they positively impact patient experience and support behavior change at the point of care. The IndiGO tool brings revolutionary modeling technology together with a simple, patient-facing output that can be used in primary care settings to support discussions with patients about behavior and risk. All too often, conversations about weight, smoking or medication adherence occur to the patient as a list of ‘should’s’ and ‘should-not’s,’ – if they happen at all. IndiGO’s presentation of risks and the relative value of behavior change empowers patients to choose and become engaged in their healthcare. IndiGO is a great fit for Colorado Beacon because it puts the patient at the center of the decision-making process.”

IndiGO analyzes person-specific health information from a patient’s electronic health record, then applies advanced algorithms to incorporate clinical evidence related to diseases, behaviors, and interventions. The results generated by IndiGO provide a graphical representation of an individual’s risk of having a heart attack or stroke, developing diabetes, and the predicted impact of interventions, such as lifestyle changes and medications that are most effective at reducing these risks. IndiGO and individualized guidelines can be used at the point-of-patient care, involving the patient in the decision making process and improving collaboration between patient and provider.

About IndiGO

Archimedes IndiGO is a unique decision support tool designed for use by physicians and other healthcare providers (nurses, care managers, health coaches) and patients. IndiGO calculates and displays the risk a patient has of adverse events - such as heart attacks, strokes, and onset of diabetes. IndiGO then suggests and prioritizes the medications and/or lifestyle interventions that have the greatest impact on reducing that risk. IndiGO is designed for use within ACOs, medical groups, integrated delivery networks (IDN), independent practice associations (IPA), and patient-centered medical homes (PCMH).

About Archimedes

Archimedes Inc. is a healthcare modeling organization. Its core technology - the Archimedes Model - is a clinically realistic, mathematical model of human physiology, diseases, interventions and healthcare systems. The Model is continually validated by comparing the results of simulated trials to the results of real multi-national clinical trials and cohort studies.

Through innovations such as IndiGO and ARCHeS, Archimedes helps people understand the implications of their decisions and for the last 15 years has been relied upon to answer complex, real world questions for health plans, health systems, medical groups, pharmaceutical companies, researchers, and other organizations in the United States and Europe. Archimedes, a Kaiser Permanente Innovation, is based in San Francisco, California. For more information on the company, visit our website at www.archimedesmodel.com.